-
1
-
-
84871607506
-
-
[eMedTV website] Updated September 1, 2006. Accessed May 12, 2010
-
Schoenstadt A,. Prostate cancer survival rates. [eMedTV website]. Available at: http://prostate-cancer.emedtv.com/prostate-cancer/prostate-cancer- survival-rates-p2.html. Updated September 1, 2006. Accessed May 12, 2010.
-
Prostate Cancer Survival Rates
-
-
Schoenstadt, A.1
-
3
-
-
67649528138
-
Collective cell migration in morphogenesis, regeneration and cancer
-
Friedl P, Gilmour D,. Collective cell migration in morphogenesis, regeneration and cancer. Nat Rev Mol Cell Biol 2009; 10: 445-457.
-
(2009)
Nat Rev Mol Cell Biol
, vol.10
, pp. 445-457
-
-
Friedl, P.1
Gilmour, D.2
-
4
-
-
0025875889
-
Acceleration of human prostate cancer growth in vivo by factors produced by prostate and bone fibroblasts
-
Gleave M, Hsieh JT, Gao CA, von Eschenbach AC, Chung LW,. Acceleration of human prostate cancer growth in vivo by factors produced by prostate and bone fibroblasts. Cancer Res 1991; 51: 3753-3761.
-
(1991)
Cancer Res
, vol.51
, pp. 3753-3761
-
-
Gleave, M.1
Hsieh, J.T.2
Gao, C.A.3
Von Eschenbach, A.C.4
Chung, L.W.5
-
5
-
-
0030695024
-
Inhibition of vascular endothelial cell growth factor suppresses the in vivo growth of human prostate tumors
-
Kirschenbaum A, Wang J-P, Ren M, Schiff JD, Aaronson SA, Droller MJ, Ferrara N, Holland JF, Levine AC,. Inhibition of vascular endothelial cell growth factor suppresses the in vivo growth of human prostate tumors. Urol Oncol Semin Orig Invest 1997; 3: 3-10.
-
(1997)
Urol Oncol Semin Orig Invest
, vol.3
, pp. 3-10
-
-
Kirschenbaum, A.1
Wang, J.-P.2
Ren, M.3
Schiff, J.D.4
Aaronson, S.A.5
Droller, M.J.6
Ferrara, N.7
Holland, J.F.8
Levine, A.C.9
-
6
-
-
0034085954
-
Fibroblast growth factor 2: Its structure and property, paracrine function, tumor angiogenesis, and prostate-related mitogenic and oncogenic functions
-
Dow JK, deVere White RW,. Fibroblast growth factor 2: Its structure and property, paracrine function, tumor angiogenesis, and prostate-related mitogenic and oncogenic functions. Urology 2000; 55: 800-806.
-
(2000)
Urology
, vol.55
, pp. 800-806
-
-
Dow, J.K.1
Devere White, R.W.2
-
7
-
-
0034490943
-
Hepatocyte growth factor secreted by prostate-derived stromal cells stimulates growth of androgen-independent human prostatic carcinoma cells
-
Nakashiro K, Okamoto M, Hayashi Y, Oyasu R,. Hepatocyte growth factor secreted by prostate-derived stromal cells stimulates growth of androgen-independent human prostatic carcinoma cells. Am J Pathol 2000; 157: 795-803.
-
(2000)
Am J Pathol
, vol.157
, pp. 795-803
-
-
Nakashiro, K.1
Okamoto, M.2
Hayashi, Y.3
Oyasu, R.4
-
8
-
-
0032735610
-
Prostate stromal cell-derived hepatocyte growth factor induces invasion of prostate cancer cell line DU145 through tumor-stromal interaction
-
Nishimura K, Kitamura M, Miura H, Nonomura N, Takada S, Takahara S, Matsumoto K, Nakamura T, Matsumiya K,. Prostate stromal cell-derived hepatocyte growth factor induces invasion of prostate cancer cell line DU145 through tumor-stromal interaction. Prostate 1999; 41: 145-153.
-
(1999)
Prostate
, vol.41
, pp. 145-153
-
-
Nishimura, K.1
Kitamura, M.2
Miura, H.3
Nonomura, N.4
Takada, S.5
Takahara, S.6
Matsumoto, K.7
Nakamura, T.8
Matsumiya, K.9
-
9
-
-
78650016651
-
Monoclonal antibody targeting of N-cadherin inhibits prostate cancer growth, metastasis and castration resistance
-
et al.
-
Tanaka H, Kono E, Tran CP, et al. Monoclonal antibody targeting of N-cadherin inhibits prostate cancer growth, metastasis and castration resistance. Nat Med 2010; 16 (12): 1414-1420.
-
(2010)
Nat Med
, vol.16
, Issue.12
, pp. 1414-1420
-
-
Tanaka, H.1
Kono, E.2
Tran, C.P.3
-
10
-
-
0032887119
-
N-Cadherin expression in human prostate carcinoma cell lines. An epithelial-mesenchymal transformation mediating adhesion with stromal cells
-
Tran NL, Nagle RB, Cress AE, Heimark RL,. N-Cadherin expression in human prostate carcinoma cell lines. An epithelial-mesenchymal transformation mediating adhesion with stromal cells. Am J Pathol 1999; 155: 787-798.
-
(1999)
Am J Pathol
, vol.155
, pp. 787-798
-
-
Tran, N.L.1
Nagle, R.B.2
Cress, A.E.3
Heimark, R.L.4
-
11
-
-
0032516078
-
Regulation of transport pathways in tumor vessels: Role of tumor type and microenvironment
-
Hobbs SK, Monsky WL, Yuan F, Roberts WG, Griffith L, Torchilin VP, Jain RK,. Regulation of transport pathways in tumor vessels: Role of tumor type and microenvironment. Proc Natl Acad Sci USA 1998; 95: 4607-4612.
-
(1998)
Proc Natl Acad Sci USA
, vol.95
, pp. 4607-4612
-
-
Hobbs, S.K.1
Monsky, W.L.2
Yuan, F.3
Roberts, W.G.4
Griffith, L.5
Torchilin, V.P.6
Jain, R.K.7
-
12
-
-
84855183561
-
Prostate cancer-derived angiogenin stimulates the invasion of prostate fibroblasts
-
Jones ML, Ewing CM, Isaacs WB, Getzenberg RH,. Prostate cancer-derived angiogenin stimulates the invasion of prostate fibroblasts. J Cell Mol Med 16 (1): 193-201.
-
J Cell Mol Med
, vol.16
, Issue.1
, pp. 193-201
-
-
Jones, M.L.1
Ewing, C.M.2
Isaacs, W.B.3
Getzenberg, R.H.4
-
14
-
-
80051988763
-
Circulating tumor cells from patients with advanced prostate and breast cancer display both epithelial and mesenchymal markers
-
Armstrong AJ, Marengo MS, Oltean S, Kemeny G, Bitting RL, Turnbull JD, Herold CI, Marcom PK, George DJ, Garcia-Blanco MA,. Circulating tumor cells from patients with advanced prostate and breast cancer display both epithelial and mesenchymal markers. Mol Cancer Res 2011; 9: 997-1007.
-
(2011)
Mol Cancer Res
, vol.9
, pp. 997-1007
-
-
Armstrong, A.J.1
Marengo, M.S.2
Oltean, S.3
Kemeny, G.4
Bitting, R.L.5
Turnbull, J.D.6
Herold, C.I.7
Marcom, P.K.8
George, D.J.9
Garcia-Blanco, M.A.10
-
15
-
-
67449107298
-
Circulating tumor cells in patients with castration-resistant prostate cancer baseline values and correlation with prognostic factors
-
Goodman OB Jr, Fink LM, Symanowski JT, Wong B, Grobaski B, Pomerantz D, Ma Y, Ward DC, Vogelzang NJ,. Circulating tumor cells in patients with castration-resistant prostate cancer baseline values and correlation with prognostic factors. Cancer Epidemiol Biomarkers Prev 2009; 18: 1904-1913.
-
(2009)
Cancer Epidemiol Biomarkers Prev
, vol.18
, pp. 1904-1913
-
-
Goodman Jr., O.B.1
Fink, L.M.2
Symanowski, J.T.3
Wong, B.4
Grobaski, B.5
Pomerantz, D.6
Ma, Y.7
Ward, D.C.8
Vogelzang, N.J.9
-
16
-
-
58149165081
-
Circulating tumor cells predict survival benefit from treatment in metastatic castration-resistant prostate cancer
-
de Bono JS, Scher HI, Montgomery RB, Parker C, Miller MC, Tissing H, Doyle GV, Terstappen LW, Pienta KJ, Raghavan D,. Circulating tumor cells predict survival benefit from treatment in metastatic castration-resistant prostate cancer. Clin Cancer Res 2008; 14: 6302-6309.
-
(2008)
Clin Cancer Res
, vol.14
, pp. 6302-6309
-
-
De Bono, J.S.1
Scher, H.I.2
Montgomery, R.B.3
Parker, C.4
Miller, M.C.5
Tissing, H.6
Doyle, G.V.7
Terstappen, L.W.8
Pienta, K.J.9
Raghavan, D.10
-
17
-
-
0037319283
-
Defining the ideal cutpoint for determining PSA recurrence after radical prostatectomy. Prostate-specific antigen
-
Freedland SJ, Sutter ME, Dorey F, Aronson WJ,. Defining the ideal cutpoint for determining PSA recurrence after radical prostatectomy. Prostate-specific antigen. Urology 2003; 61: 365-369.
-
(2003)
Urology
, vol.61
, pp. 365-369
-
-
Freedland, S.J.1
Sutter, M.E.2
Dorey, F.3
Aronson, W.J.4
-
18
-
-
0035093811
-
Defining prostate specific antigen progression after radical prostatectomy: What is the most appropriate cut point
-
Amling CL, Bergstralh EJ, Blute ML, Slezak JM, Zincke H,. Defining prostate specific antigen progression after radical prostatectomy: What is the most appropriate cut point ? J Urol 2001; 165: 1146-1151.
-
(2001)
J Urol
, vol.165
, pp. 1146-1151
-
-
Amling, C.L.1
Bergstralh, E.J.2
Blute, M.L.3
Slezak, J.M.4
Zincke, H.5
-
19
-
-
77955982168
-
Tumor-stromal interactions in bone metastasis
-
Nannuru KC, Singh RK,. Tumor-stromal interactions in bone metastasis. Curr Osteoporos Rep 2010; 8: 105-113.
-
(2010)
Curr Osteoporos Rep
, vol.8
, pp. 105-113
-
-
Nannuru, K.C.1
Singh, R.K.2
-
20
-
-
78650739435
-
Malignant cells facilitate lung metastasis by bringing their own soil
-
Duda DG, Duyverman AMMJ, Kohno M, Snuderl M, Steller EJA, Fukumura D, Jain RK,. Malignant cells facilitate lung metastasis by bringing their own soil. Proc Natl Acad Sci USA 2010; 107: 21677-21682.
-
(2010)
Proc Natl Acad Sci USA
, vol.107
, pp. 21677-21682
-
-
Duda, D.G.1
Duyverman, A.2
Kohno, M.3
Snuderl, M.4
Steller, E.J.A.5
Fukumura, D.6
Jain, R.K.7
-
21
-
-
37549002543
-
Isolation of rare circulating tumour cells in cancer patients by microchip technology
-
Nagrath S, Sequist LV, Maheswaran S, Bell DW, Irimia D, Ulkus L, Smith MR, Kwak EL, Digumarthy S, Muzikansky A, Ryan P, Balis UJ, Tompkins RG, Haber DA, Toner M,. Isolation of rare circulating tumour cells in cancer patients by microchip technology. Nature 2007; 450: 1235-1239.
-
(2007)
Nature
, vol.450
, pp. 1235-1239
-
-
Nagrath, S.1
Sequist, L.V.2
Maheswaran, S.3
Bell, D.W.4
Irimia, D.5
Ulkus, L.6
Smith, M.R.7
Kwak, E.L.8
Digumarthy, S.9
Muzikansky, A.10
Ryan, P.11
Balis, U.J.12
Tompkins, R.G.13
Haber, D.A.14
Toner, M.15
-
22
-
-
78649872067
-
Isolation of circulating tumor cells using a microvortex-generating herringbone-chip
-
Stott SL, Hsu CH, Tsukrov DI, Yu M, Miyamoto DT, Waltman BA, Rothenberg SM, Shah AM, Smas ME, Korir GK, Floyd FP Jr, Gilman AJ, Lord JB, Winokur D, Springer S, Irimia D, Nagrath S, Sequist LV, Lee RJ, Isselbacher KJ, Maheshwaran S, Haber DA, Toner M,. Isolation of circulating tumor cells using a microvortex-generating herringbone-chip. Proc Natl Acad Sci USA 2010; 107: 18392-18397.
-
(2010)
Proc Natl Acad Sci USA
, vol.107
, pp. 18392-18397
-
-
Stott, S.L.1
Hsu, C.H.2
Tsukrov, D.I.3
Yu, M.4
Miyamoto, D.T.5
Waltman, B.A.6
Rothenberg, S.M.7
Shah, A.M.8
Smas, M.E.9
Korir, G.K.10
Floyd, Jr.F.P.11
Gilman, A.J.12
Lord, J.B.13
Winokur, D.14
Springer, S.15
Irimia, D.16
Nagrath, S.17
Sequist, L.V.18
Lee, R.J.19
Isselbacher, K.J.20
Maheshwaran, S.21
Haber, D.A.22
Toner, M.23
more..
|